The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi-experimental study.
Nurs Open
; 9(2): 1477-1485, 2022 03.
Article
en En
| MEDLINE
| ID: mdl-34859616
ABSTRACT
AIM:
To estimate the cost-effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool.DESIGN:
Multi-centred non-randomized controlled trial from August 2018 to March 2020 including 65 nursing homes or home care providers.METHODS:
We aim to estimate the effect of the intervention on the rate of adverse drug events as primary outcome through a quasi-experimental empirical study design. As secondary outcomes, we use hospital admissions and falls. All outcomes will be measured on patient-month level. Once the causal effect of the intervention is estimated, cost-effectiveness will be calculated. For cost-effectiveness, we include all patient costs observed by the German statutory health insurance.RESULTS:
The results of this study will inform about the cost-effectiveness of the optimized drug supply intervention and provide evidence for potential reimbursement within the German statutory health insurance system.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
/
Servicios de Atención de Salud a Domicilio
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
Nurs Open
Año:
2022
Tipo del documento:
Article
País de afiliación:
Alemania